close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

3.550 +0.070 (+2.01%)
Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Unicycive Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Unicycive Therapeutics, Inc. (Nasdaq:UNCY) today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the Guggenheim 3rd Annual Healthcare Innovation Conference on Tuesday,... 
Via B2i Digital
News headline image
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026 - UNCY
A securities class action alleges Unicycive Therapeutics resubmitted its oxylanthanum carbonate New Drug Application without ever inspecting its third-party manufacturer's facility for cGMP compliance.... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY UPCOMING DEADLINE: Levi & Korsinsky Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors With Significant Losses to Contact the Firm Before November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
UNCY Deadline: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
News headline image
UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY Investor Alert: Unicycive Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt
A securities class action alleges Unicycive Therapeutics assured the market that its third-party manufacturer had made "significant progress" toward FDA compliance without ever inspecting the facility,... 
From SueWallSt
Via GlobeNewswire
News headline image
UNCY Deadline Alert: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of Securities Class Action Deadline on November 2, 2026
A securities class action alleges Unicycive Therapeutics told investors its third-party manufacturer had made "significant progress" toward regaining FDA compliance, while the Company had never... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
UNCY Class Action Lawsuit - Robbins LLP Reminds Unicycive Therapeutics, Inc. Investors of the November 2, 2026 Lead Plaintiff Deadline
San Diego, California--(Newsfile Corp. - October 26, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or... 
Via Newsfile
Topics Lawsuit
News headline image
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
From Unicycive Therapeutics, Inc.
Via JCN Newswire
News headline image
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission and PDUFA Date of March 25, 2027
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate... 
Via B2i Digital
News headline image
Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY DEADLINE: SueWallSt Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
A securities class action alleges Unicycive Therapeutics told shareholders its oxylanthanum carbonate application was on track without ever inspecting its third-party manufacturer's facility for cGMP... 
From SueWallSt
Via GlobeNewswire
News headline image
UNCY Shareholder Alert: Unicycive Therapeutics, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
A securities class action alleges Unicycive Therapeutics leaned on a contract manufacturer already cited by the FDA for cGMP deficiencies, without verifying the vendor's compliance status, before the... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
UNCY DEADLINE: Levi & Korsinsky Reminds Unicycive Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of November 2, 2026 in the Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Securities Class Action
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities Lawsuit - Contact SueWallSt
A securities class action contends Unicycive Therapeutics promised shareholders an FDA decision on June 29, 2026 and a commercial launch of oxylanthanum carbonate "later this year," while allegedly... 
From SueWallSt
Via GlobeNewswire
News headline image
UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky
A securities class action names Unicycive Therapeutics' Chief Executive Officer and Chief Financial Officer as individual defendants under Section 20(a) control person claims, alleging they controlled... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to the Lead Plaintiff Deadline on November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
UNCY Investor Alert: Unicycive Therapeutics, Inc. Securities Class Action Notice - Contact Levi & Korsinsky
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Unicycive Therapeutics, Inc. Investors with Large Losses to Contact the Firm Seeking Lead Plaintiff Role
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
UNCY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
UNCY Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Securities Class Action Against Unicycive Therapeutics, Inc.
San Diego, California--(Newsfile Corp. - October 5, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class... 
Via Newsfile
Topics Lawsuit
News headline image
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.